Skip to content

C-SEE: what changed

BE 0805.055.359NACE 32.500, Manufacture of medical and dental instruments and suppliesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€58,085
2024 · €52,751+€5,334
Equity
€112,144
2024 · €54,892+€57,252
Cash
€131,702
2024 · €76,547+€55,155
Balance sheet total
€147,027
2024 · €87,216+€59,812

Largest movements

2024 to 2025
Assets
  • Cash +€55,155

    up €55,155 (+72.1%), from €76,547 to €131,702

    mainly Net result for the year (+€58,085) and Tax, wage and social debts (+€6,521)

  • Receivables within one year +€4,551

    up €4,551 (+42.7%), from €10,669 to €15,220

    of which Trade receivables: +€4,512

Equity and liabilities
  • Reserves +€57,252

    up €57,252 (+110%), from €51,892 to €109,144

  • Tax, wage and social debts +€6,521

    up €6,521 (+32.7%), from €19,935 to €26,456

  • Trade debts -€4,646

    down €4,646 (-79.3%), from €5,857 to €1,210

Income statement
  • Gross operating margin +€4,802

    up €4,802 (+6.5%), from €73,844 to €78,646

  • Staff costs -€3,150

    down €3,150 (-51.3%), from €6,140 to €2,990

  • Taxes +€2,071

    up €2,071 (+15.1%), from €13,735 to €15,805

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €52,751
Gross operating margin +€4,802
Staff costs +€3,150
Other operating charges -€251
Financial income +€20
Financial charges -€317
Taxes -€2,071
Result 2025 €58,085
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€55,988
Investment €0
Financing -€833
Cash 2024 €76,547
Net result for the year +€58,085
Receivables within one year -€4,551
Deferred charges and accrued income -€106
Trade debts -€4,646
Tax, wage and social debts +€6,521
Other debts +€962
Accrued charges and deferred income -€276
Contributions, distributions and other -€833
Cash 2025 €131,702
brings cash intakes cash out
Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €87,216 €147,027 +€59,812 +68.6%
Current assets 29/58 €87,216 €147,027 +€59,812 +68.6%
Amounts receivable within one year 40/41 €10,669 €15,220 +€4,551 +42.7%
Trade receivables 40 €10,656 €15,168 +€4,512 +42.3%
Other amounts receivable 41 €13 €51 +€38 +300%
Cash at bank and in hand 54/58 €76,547 €131,702 +€55,155 +72.1%
Deferred charges and accrued income 490/1 - €106 +€106
Total equity and liabilities 10/49 €87,216 €147,027 +€59,812 +68.6%
Equity 10/15 €54,892 €112,144 +€57,252 +104%
Contributions 10/11 €3,000 €3,000 = 0.0%
Reserves 13 €51,892 €109,144 +€57,252 +110%
Distributable reserves 133 €51,892 €109,144 +€57,252 +110%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €32,323 €34,883 +€2,560 +7.9%
Amounts payable within one year 42/48 €32,047 €34,883 +€2,836 +8.9%
Trade debts 44 €5,857 €1,210 -€4,646 -79.3%
Suppliers 440/4 €5,857 €1,210 -€4,646 -79.3%
Advances received on contracts in progress 46 €2,500 €2,500 = 0.0%
Taxes, remuneration and social security 45 €19,935 €26,456 +€6,521 +32.7%
Taxes 450/3 €19,935 €26,456 +€6,521 +32.7%
Other amounts payable 47/48 €3,755 €4,717 +€962 +25.6%
Accrued charges and deferred income 492/3 €276 €0 -€276 -100%
Remuneration, social security and pensions 62 €6,140 €2,990 -€3,150 -51.3%
Other operating charges 640/8 €1,050 €1,301 +€251 +23.9%
Gross operating margin 9900 €73,844 €78,646 +€4,802 +6.5%
Operating profit (loss) 9901 €66,654 €74,355 +€7,701 +11.6%
Financial income 75/76B €1 €21 +€20 +3,984%
Recurring financial income 75 €1 €21 +€20 +3,984%
Financial charges 65/66B €169 €485 +€317 +188%
Recurring financial charges 65 €169 €485 +€317 +188%
Profit (loss) for the period before taxes 9903 €66,486 €73,890 +€7,404 +11.1%
Income taxes 67/77 €13,735 €15,805 +€2,071 +15.1%
Profit (loss) for the period 9904 €52,751 €58,085 +€5,334 +10.1%
Profit (loss) for the period to be appropriated 9905 €52,751 €58,085 +€5,334 +10.1%

Value

latest balance sheet 30-09-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€253,994 to €333,162

Midpoint €286,981 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €112,144
Capitalised earnings €395,843 to €554,180
Indication €253,994 to €333,162

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€112,144
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€112,144

Capitalised earnings

net result for the year (9904)
2025
€58,085
2024
€52,751
Average result
€55,418
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€395,843 / €461,817 / €554,180

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 11 November 2026 via checked.be.